Independent Intelligence
Research, legal analysis, and market intelligence from Knightsbridge — covering the intersections of finance, regulation, and emerging technology.

Research
KXCO's FDA Ontology Ranked INO-3107 First. The FDA Approved It.
For nine days the first screen of KXCO's FDA ontology put Inovio's INO-3107 at the top of its ranking of FDA decisions due in the next 90 days. The FDA approved it on its target date, and the record took in the FDA's letter the same night.
Shayne Heffernan13 min read
Financial Research
Legal & Regulatory
Technology & Fintech
Company News
All Knightsbridge Insights articles are also available on Live Trading News
← Back to Live Trading News








